SKI Market

A+| A| A-|

Indian Indices

Sensex

76,488.96 1,073.61
( 1.42%)

Global Indices

Nasdaq

50,600.73 294.06
(0.58%)

Dow Jones

7,493.73 27.01
(0.36%)

Hang Seng

65,182.04 1,842.97
(2.91%)

Nikkei 225

10,474.02 30.55
(0.29%)

Forex

USD-INR

96.29 -0.42
(-0.43%)

EUR-INR

111.82 -0.44
(-0.39%)

GBP-INR

129.28 -0.40
(-0.31%)

JPY-INR

0.61 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7898972

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

33.88

109098.01

EPS(TTM)

Face Value()

Div & Yield %

38.58

0.61

Back

Dolfin Rubbers standalone net profit rises 3.85% in the September 2025 quarter

Nov 12,2025

Net profit of Dolfin Rubbers rose 3.85% to Rs 1.08 crore in the quarter ended September 2025 as against Rs 1.04 crore during the previous quarter ended September 2024. Sales rose 18.40% to Rs 39.90 crore in the quarter ended September 2025 as against Rs 33.70 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	39.90	33.70	18
OPM %	4.59	5.82	-
PBDT	1.67	1.82	-8
PBT	1.22	1.32	-8
NP	1.08	1.04	4

76,488.96 1,073.61 ( 1.42%)

50,600.73 294.06 (0.58%)

7,493.73 27.01 (0.36%)

65,182.04 1,842.97 (2.91%)

10,474.02 30.55 (0.29%)

96.29 -0.42 (-0.43%)

111.82 -0.44 (-0.39%)

129.28 -0.40 (-0.31%)

0.61 0.00 (-0.48%)